Pharmaceuticals News and Research

RSS

Angiotech Pharmaceuticals plans US launch of Option Inferior Vena Cava Filter

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP), today announced the commercial launch of the Option(TM) Inferior Vena Cava (IVC) Filter in the United States, following FDA 510(k) clearance in June and a limited pre-launch in July. Angiotech holds exclusive worldwide rights to market and distribute the Option IVC Filter, which it obtained in a license agreement with privately held Rex Medical, LP (Rex Medical), as announced in March 2008.

20 Aug 2009

Poniard Pharmaceuticals may sell up to $60 million of its registered common stock to finance its picoplatin clinical development and commercialization programs

...

20 Aug 2009

SCS becomes the first IT systems integration services provider to join Medidata’s ASPire to Win program

Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that Sumisho Computer Systems Corporation (SCS) has become the first IT systems integration services provider to join Medidata’s ASPire to Win® program for contract research organizations (CROs) and service providers.

20 Aug 2009

USPTO grants MultiCell Technologies patent for its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announced today it has been granted U.S. patent 7,566,567 by the United States of America Patent and Trademark Office covering its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines.

20 Aug 2009

Wraser purchases Trezix oral capsule product from e5 Pharma

WraSer Pharmaceuticals, LLC (WraSer) announced that it has purchased the Trezix® Oral Capsule product from e5 Pharma, LLC. With the purchase, WraSer is granted full rights to market and distribute Trezix® in the United States.

20 Aug 2009

Zila starts proxy vote on proposed merger with TOLMAR Holding

Zila, Inc. announced that Proxy Statements and Proxies have been mailed to its stockholders in order to allow them to vote on the proposed merger with a subsidiary of TOLMAR Holding, Inc. Under the terms of the merger agreement, if approved by the stockholders, each Zila stockholder would be entitled to receive $0.45 per share in cash. Tolmar is a privately held, pharmaceutical research, development, manufacturing and commercial operations company.

20 Aug 2009

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

Inovio Biomedical Corporation (NYSE AMEX: INO) (“Inovio”) today reported financial results for the three and six months ended June 30, 2009. Total revenue of $2.5 million and $2.9 million for the three and six months ended June 30, 2009, compared to $663,000 and $1.3 million for the three and six months ended June 30, 2008, respectively.

20 Aug 2009

John R. Walsh to be responsible for continued expansion of IMS' payer and government solution initiatives

IMS Health today announced that John R. Walsh has been named senior vice president, Payer and Government Solutions, a new position. Previously, Walsh was senior vice president, Strategy and Business Development for IMS. He continues to report to David R. Carlucci, IMS chairman and CEO, and will be based in Norwalk, CT.

20 Aug 2009

Vanderbilt enters Chemical Biology Consortium as a Chemical Diversity Center to develop cancer treatment drugs

Vanderbilt University has been selected as one of 10 centers in the nation to participate in the Chemical Biology Consortium (CBC), a major new initiative to facilitate the discovery and development of new agents to treat cancer.

20 Aug 2009

Weikang Bio-Technology Group announces increased revenues for second-quarter of 2009

Weikang Bio-Technology Group Co., Inc. (OTC Bulletin Board: WKBT; "WKBT"), a Chinese producer of OTC pharmaceuticals and traditional Chinese medicine ("TCM") products, reported financial results for its second quarter ended June 30, 2009.

20 Aug 2009

U.S.District Court ruling favors Merck in patent infringement suit against Teva Pharmaceuticals

Merck & Co., Inc. announced today that the U.S. District Court for the District of New Jersey has ruled in Merck's favor in a patent infringement suit against Teva Pharmaceuticals USA Inc. (Teva).

20 Aug 2009

Aton Pharma markets preservative-free drugs for glaucoma

Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.

20 Aug 2009

Catalent Pharma Solutions completes the first FDA general cGMP audit

Catalent Pharma Solutions announces the recent successful completion of the first FDA general cGMP audit and pre-approval inspection of its Buenos Aires, Argentina pharmaceutical softgel facility, with no reported observations on FDA Form 483.

20 Aug 2009

Supplemental Manufacturing and Ingredients forges manufacturing agreement with HealthSport's subsidiary, InnoZen

InnoZen, Inc., a wholly owned subsidiary of HealthSport, Inc. (OTC Bulletin Board: HSPO) announced today that it has entered into a manufacturing agreement with Supplemental Manufacturing and Ingredients, LLC ("SMI"), a cGMP certified manufacturer based in Tempe, Arizona. As part of the Agreement, SMI has committed to purchasing $1,000,000 worth of HealthSport common stock.

20 Aug 2009

Dey's Albuterol Sulfate Inhalation Solution lots stolen in Texas

Dey L.P., a subsidiary of Mylan Inc., today issued an advisory regarding two lots of its Albuterol Sulfate Inhalation Solution, 0.083%, unit-dose vials. The lots were on a tractor-trailer that was stolen in McKinney, Texas.

20 Aug 2009

AMDL reports revenues of $3.2 million for second quarter of 2009

AMDL Inc., a US-based pharmaceutical company with major operations in China, today reported unaudited results and the filing of its Form 10-Q with the Securities and Exchange Commission ("SEC") for fiscal second quarter 2009.

19 Aug 2009

Mullti-million dollar ad campaigns supporting health overhaul launched

Various advertising campaigns take to the airwaves. Among their messages are the moral imperative of reform and the importance of cooperation.

19 Aug 2009

Mylan files lawsuit against Pittsburgh Post-Gazette, Post-Gazette reporters

Mylan Inc. (Nasdaq: MYL) today announced that the company and its subsidiary Mylan Pharmaceuticals Inc. filed a civil lawsuit in the Circuit Court of Monongalia County, W.Va., against the Pittsburgh Post-Gazette, Post-Gazette reporters Len Boselovic and Patricia Sabatini, and others as yet unknown.

19 Aug 2009

H1N1 vaccine orders top 1 billion, WHO Says

"Northern hemisphere countries have so far ordered more than one billion doses of swine flu vaccine, the World Health Organisation said Tuesday, sparking warnings over shortages," Agence France-Presse reports. While some countries, including Greece, The Netherlands, Canada and Israel, have ordered enough vaccine to inoculate their citizens, "[o]thers, such as Germany, the United States, Britain and France, have put in orders that would cover between 30 and 78 percent of people," the news service writes.

19 Aug 2009

U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals

Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad((R)) mucoadhesive buccal tablets (MBT) to treat oropharyngeal candidiasis (OPC).

19 Aug 2009

Pharmaceuticals News and Research

Angiotech Pharmaceuticals plans US launch of Option Inferior Vena Cava Filter

Poniard Pharmaceuticals may sell up to $60 million of its registered common stock to finance its picoplatin clinical development and commercialization programs

SCS becomes the first IT systems integration services provider to join Medidata’s ASPire to Win program

USPTO grants MultiCell Technologies patent for its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines

Wraser purchases Trezix oral capsule product from e5 Pharma

Zila starts proxy vote on proposed merger with TOLMAR Holding

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

John R. Walsh to be responsible for continued expansion of IMS' payer and government solution initiatives

Vanderbilt enters Chemical Biology Consortium as a Chemical Diversity Center to develop cancer treatment drugs

Weikang Bio-Technology Group announces increased revenues for second-quarter of 2009

U.S.District Court ruling favors Merck in patent infringement suit against Teva Pharmaceuticals

Aton Pharma markets preservative-free drugs for glaucoma

Catalent Pharma Solutions completes the first FDA general cGMP audit

Supplemental Manufacturing and Ingredients forges manufacturing agreement with HealthSport's subsidiary, InnoZen

Dey's Albuterol Sulfate Inhalation Solution lots stolen in Texas

AMDL reports revenues of $3.2 million for second quarter of 2009

Mullti-million dollar ad campaigns supporting health overhaul launched

Mylan files lawsuit against Pittsburgh Post-Gazette, Post-Gazette reporters

H1N1 vaccine orders top 1 billion, WHO Says

U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring